The components of the angiotensin-(1-7) system are differentially expressed during follicular wave in cattle

J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):275-83. doi: 10.1177/1470320313491996. Epub 2013 Jun 13.

Abstract

Introduction: This study was based on the hypothesis that some components of the angiotensin-(1-7) (Ang-(1-7)) system are differentially expressed during follicular development and can be involved in the follicular health/atresia transition in bovine.

Material and methods: The largest (F1) and second largest follicles (F2) were collected from cows before (Day 2), during (Day 3), or after (Day 4) the expected moment of follicular deviation. In the second experiment, F1 was induced to atresia through intrafollicular injection of fulvestrant (estrogen receptor-antagonist) and, in both experiments, mRNA expression of the Mas receptor, ACE2, NEP, and PEP was evaluated in the granulosa and theca cells.

Results: The mRNA expression of Mas receptor was upregulated in the granulosa cells of F2 after the establishment of follicular deviation, while PEP mRNA increased during and after the deviation process. The mRNA expression of ACE2 was upregulated in the granulosa cells of F1 during and after the follicular deviation. The mRNA expression of NEP was not regulated in F1 and F2. Mas receptor expression increased in the F1 induced to atresia.

Conclusions: mRNA for Mas receptor, ACE2, and PEP are differentially expressed in granulosa cells throughout follicular development and the Mas receptor can be involved with the establishment of follicular dominance.

Keywords: ACE2; Mas receptor; NEP; PEP; bovine; follicular deviation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / genetics
  • Angiotensin I / metabolism*
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Cattle
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Female
  • Follicular Atresia / drug effects
  • Follicular Atresia / genetics
  • Fulvestrant
  • Gene Expression Profiling*
  • Granulosa Cells / drug effects
  • Granulosa Cells / metabolism
  • Neprilysin / genetics
  • Neprilysin / metabolism
  • Ovarian Follicle / drug effects
  • Ovarian Follicle / enzymology
  • Ovarian Follicle / metabolism*
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism*
  • Peptidyl-Dipeptidase A / genetics
  • Peptidyl-Dipeptidase A / metabolism
  • Prolyl Oligopeptidases
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism
  • Serine Endopeptidases / genetics
  • Serine Endopeptidases / metabolism
  • Theca Cells / drug effects
  • Theca Cells / metabolism

Substances

  • Peptide Fragments
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Receptors, G-Protein-Coupled
  • Fulvestrant
  • Estradiol
  • Angiotensin I
  • Peptidyl-Dipeptidase A
  • Angiotensin-Converting Enzyme 2
  • Serine Endopeptidases
  • Prolyl Oligopeptidases
  • Neprilysin
  • angiotensin I (1-7)